chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started feeling joint pain; Muscle pain on hip, calf and thigh; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Started feeling joint pain) and MYALGIA (Muscle pain on hip, calf and thigh) in an 81-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch nos. 032L2DA and 022M2DA) for COVID-19 vaccination. No Medical History was provided by the reporter. Concomitant products included CELECOXIB (CELEBREX) and ACETAMINOPHEN for Pain.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced ARTHRALGIA (Started feeling joint pain) and MYALGIA (Muscle pain on hip, calf and thigh). At the time of the report, ARTHRALGIA (Started feeling joint pain) and MYALGIA (Muscle pain on hip, calf and thigh) had resolved. Not Provided      The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) was unknown.       No treatment information was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow up received on 23 APR 2021: Updated Event outcome and product indication. On 20-Jul-2021: Follow up received on 20 JUL 2021: Event outcome provided.
Patient reports an area of discoloration in nasal periphery x 6 days. Patient states that he woke up last Saturday 5/8/21 after a nap post COVID-19 vaccine with this spot in vision. He reports that he noticed a light in vision, OS today. He reports some occasional ache in OS. Reports stable floaters, OU. Intraretinal Hemorrhage. 6 days post second dose vaccine. Had second pfizer vaccine Saturday 05/08/2021, noticed a blurred spot in central VA Monday. Intraretinal, no leak, no CNV or vasculitis. White center, Probable incomplete retinal blockage versus Roth spot. Endocarditis unlikely but check for heart murmur, echo if murmur. See PCP for systemic eval - check CBC w diff (for hematologic dis), coags for both hyper and hypo coagulable state as has been reported post COVID-19 vaccine. Also check for DM, HTN, although unlikely.
1/15 vaccination Early afternoon, fatigue set in. That night i spiked fever over 100 and chills fever broke 1/16 pre syncopal episodes. Did pass out while sitting down. By noon, I had fever and chills, fatigue. broke that afternoon. By 7pm I got another fever, chills, and had abdominal pain with GERD. Was not due to food as hadn't ate. Couldn't speak due to the pain. No medication taken. Husband called PCM worried about hydration. Took Tylenol and kept fluid down. Big inflammatory response.  Symptoms lasted for 48 hours
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a elderly patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm (serious criteria disability) and mobility decreased (serious criteria disability). On an unknown date, the outcome of the pain in arm and mobility decreased were recovered/resolved. The reporter considered the pain in arm and mobility decreased to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. This was one of the 4 patients involving both male and female over the age of 65 years old. After receiving SHINGRIX vaccine, the patient experienced intense pain after the shot. The reporter stated that patient complained of whole arm pain with the shoulder and had decreased mobility of the arm. The patient went to emergency room for the pain and received medication but were not admitted. The reporter stated that after a couple of days the pain was better, but it was very intense for 24 hours and then it started to decline. The reporter reviewed her technique and stated that she was using a new 25g needle to give the injection after removing the needle that was used to puncture the vial stoppers. The reporter noted it was disabling to them because he/she was limited in mobility of that arm. The reporter didn't have specifics of the patient at the time of this report, but would be able to get that information.
A very tender swollen lymph node in armpit (same side as shot); Swollen lymph node in armpit (same side as shot).; Shortness of breath; Severe nausea; Diarrhea 12 hours after second shot; This is a spontaneous report from a contactable consumer, the parent.   A 17-year-old non-pregnant female patient (not pregnant at the time of vaccination) received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unspecified date in 2021 (at the age of 17 years-old) as dose 2, single for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 10Apr2021 (at the age of 17-years-old) as dose 1, single for COVID-19 immunisation and experienced a tender swollen lymph node in her armpit (same side as the shot) that began a day or two after the first vaccine. On an unspecified date in 2021, the patient had experienced a very tender swollen lymph node in her armpit (same side as shot), shortness of breath for about a week after the second vaccine, severe nausea and diarrhea 12 hours after the second vaccine. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
THIS WAS A BOOSTER SHOT.  PAIN IN MY LEFT LEG HAD TO LEAN ON MY SISTER TO WALK.  THIS OCCURRED ABOUT TWO HOURS AFTER THE SHOT..  LATER THAT EVENING HAD BODY ACHES WHICH LASTED TWO DAYS. ALSO LOST BY BALANCE AND HAD TO HOLD ON TO THE WALL, ETC. AS I WALKED AROUND THE HOUSE   I  ALSO HAD DISCOMFORT AT THE INJECTION SITE.
When I was giving patient her second Pfizer vaccine, she stated that on the first shot on 8/24/21, on the following day, she had side effects. She reported that she couldn't get out of bed and had to use restroom 3 times.
Site of her injection is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Site of her injection is swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Site of her injection is swollen). At the time of the report, VACCINATION SITE SWELLING (Site of her injection is swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product was not provided.  Patient did not received any treatment.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This case was reported by a nurse via call center representative and described the occurrence of nausea in a 11-year-old male patient who received BOOSTRIX (batch number 7Y29Z, expiry date 17th August 2019). On 31st July 2017, the patient received the 1st dose of BOOSTRIX .5 ml. On 31st July 2017, immediately after receiving BOOSTRIX, the patient experienced nausea, abdominal pain, tiredness and vomiting. On 31st July 2017, the outcome of the vomiting was recovered/resolved. On an unknown date, the outcome of the nausea was recovering/resolving and the outcome of the abdominal pain and tiredness were unchanged. The reporter considered the nausea, abdominal pain, tiredness and vomiting to be possibly related to BOOSTRIX. Additional details were provided as follows: The patient complained of nausea immediately following vaccination with BOOSTRIX. Within minutes, the patient vomited twice. One hour after vaccination, the patient experienced abdominal soreness and tiredness. The clinic had kept the patient for observation over the hour, and the patient reported no further vomiting, but continued abdominal soreness, mild nausea, and tiredness.
Passed out in the evening during church service. Began feeling nauseous and then passed out. Afterwards was clammy and shaking. Since the event, blood pressure has been low upon standing and heart rate has been increased.
Information has been received from a registered nurse concerning a female patient who on unspecified date was vaccinated with a dose of PNEUMOVAX 23. Subsequently the patient experienced an unspecified allergy. At the time of the report the patient's present status was unknown. Subsequently on 24-SEP-2010, the patient experienced shingles (WAES 1009USA05530). Additional information has been requested.
This case was reported by a pharmacist via sales rep and described the occurrence of shivering in a 84-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date unknown). On 27th March 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shivering (serious criteria hospitalization), hypermetabolism and dehydration. On an unknown date, the outcome of the shivering, hypermetabolism and dehydration were recovered/resolved. It was unknown if the reporter considered the shivering, hypermetabolism and dehydration to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The patient experienced uncontrollable shivering after vaccination, she could not stop and was admitted to the hospital for several days. The patient was fine, pharmacist did not know how soon these events occurred after vaccination. The patient's primary physician recommended that the patient should not receive second dose due to the severity of the reaction.
UrticariaPruritus, Left deltoid erythema, swelling, pruritic at vaccine site Narrative:
Started with sore arm in early afternoon, as expected and as experienced with the first and second doses of the vaccine.  By early evening I started experiencing moderate aches in my ankle joints and it was very painful to walk.  By the time I went to bed @ 9:30 pm the pain had progressed to many more joints and I began to feel extremely chilled.  At 10:30 pm I turned on my heated mattress pad, which helped the chills, but the pain in my joints kept waking me up repeatedly.  By 1:30 am 11-23-2021 I could not stand the pain any longer and got out of bed to find some pain relief medication, falling once in the attempt.  I took 1 tablet of Naproxen and about 30 minutes later the pain had dimmed enough that I was able to get back to sleep.  The joint pain continued Tuesday, 11-23-2021, and I have continued to take one Naproxen tablet- 225 mg every 8 hours to keep the pain bearable.  As of today, Wednesday, 11-24-2021, the joint pain is still present, but is gradually lessening.
This spontaneous prospective pregnancy report as received from a nurse practitioner states that a female patient was tested for varicella titers because patient works in healthcare. Nurse practitioner states results of varicella titers were negative ("not showing immunity") so patient was vaccinated with VARIVAX (Merck) subcutaneous 0.5 ml once (LOT # reported as H020673 EXP DATE November 2014) on 24-MAR-2014. Nurse practitioner states at the time of VARIVAX (Merck) vaccination, an unspecified pregnancy test was completed and results were negative. Nurse practitioner states patient was seen in office on 11-APR-2014 reported as today for a follow up visit and an unspecified pregnancy test was completed with positive results. Nurse practitioner states patient was near 5 weeks gestation which means at vaccination, she would have been near 3 weeks gestation. The patient became pregnant with an estimated LMP of 17-FEB-2014 and an estimated EDD of 24-NOV-2014. The patient sought medical attention, she did not receive any treatment and the patient was reported as doing well. The pregnancy outcome was pending. Additional information has been requested.
the patient experienced unspecified allergic reaction after receiving his first dose of GARDASIL 9; This spontaneous report was received from a consumer (the patient's mother) via a company representative and refers to a 12-year-old male patient. His concurrent conditions, medical history and concomitant medications were not reported.  On an unknown date the patient was vaccinated with the first dose of human papilloma virus rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (dose, route of administration, anatomical location, lot number and expiry date were not provided) for prophylaxis.  On an unknown date, after vaccination with human papilloma virus rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), the patient experienced an unspecified allergic reaction. The patient's mother stated, that he also ate some cashews before experiencing the unspecified allergic reaction and that she was not sure if the patient might be allergic to cashews. As a treatment the patient took "a couple of doses" of diphenhydramine (BENADRYL) but it did not help him. The patient would visit allergist on 24-MAY-2019.   The outcome of unspecified allergic reaction and the relatedness between the event and human papilloma virus rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) were not provided.
A day after the vaccine, I started itching , the itching was localized to arms and soon to my back. Having allergies , I started on my OTC medications to include Hydrocortisone cream . As the days progressed, the rash was over my entire body to include swelling of face and legs.
Expired vaccine received; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021 at 2:05 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021 at 2:05 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine received). On 24-Sep-2021 at 2:05 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was reported. No treatment medications were provided.  The patient did not have any adverse events and did not require any medical attention after receiving the dose. No problems were reported from patient.
Within hours of the second injection of the Pfizer\BioNTech vaccine I began to experience hearing loss in my right ear. This was a Monday. That day I went into Urgent Care to see if my ears were clogged. They flushed my ears, but did not see a blockage in my right ear. They felt there may have been an infection in the inner ear, gave me an antibiotic ear drop which I took for 2 days until I followed up with my primary care physician on Wednesday. My primary care physician added a steroid to my treatment and asked me to wait 3 days. With no improvement I went to ENT the next week (within 8 days of the injection) and was diagnosed with total hearing loss in my right ear. The nerve had died due to some sort of viral infection.
SYMPTOMS OF SINUSITIS HEADACHE SINUS PRESSURE; FATIGUE; MUSCLE ACHES; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 14-AUG-2021, the subject experienced symptoms of sinusitis headache sinus pressure. On 14-AUG-2021, the subject experienced fatigue. On 14-AUG-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from symptoms of sinusitis headache sinus pressure, fatigue, and muscle aches. This report was non-serious.
Headache, Body Ache, Chills, Stomach pain, Fever, Flu like symptoms. Soreness at vaccination site, left arm. 24 hours then weak for another 24 hours.
The patient started having repetitive excessive eye blinking 4 days ago as above. This started several hours after getting his vaccines at the health department. He got the varicella, MMR, and KINRIX vaccines that day. He never had any fever or rash or other side effects from the vaccine. Since that time, he is continued to have repetitive eye blinking, almost continuously throughout the day. He has been feeling well, with good appetite and energy levels. He is sleeping well. He has never had a history of tic behaviors in the past. He has not had any recent illnesses or symptoms that they can recall.
Tested positive for COVID on 8/20/2021.   Symptoms: Headache, congestion, sinus pressure, cough.
Approx 22-23 hrs post vaccine, I began to run a fever and have aches. Later that same day, I began to have rigors and a fever up to 103. I ran fever for approx 2 days with aches, fatigue and chills. On day 2 I had body sweats.
Malaise; This case was reported by a consumer via call center representative and described the occurrence of malaise in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced malaise. On an unknown date, the outcome of the malaise was recovered/resolved.   It was unknown if the reporter considered the malaise to be related to Shingrix.  Additional information received were as follows: This case was reported by the patient's wife. The age at vaccination was not reported. The reporter reported that the patient received experienced malaise for approximately 1 day. The reporter consented to follow up. This case was linked with US2019143112, reported by the same reporter.
pain; held xeljanz in the setting of getting her covid booster and recently resumed; This is a spontaneous report from a contactable Physician. This Physician reported for 47-year-old female patient in response to HCP follow-up letter sent to nurse in cross referenced case that included: This is a spontaneous report from a contactable physician.   A 47-years-old female patient received bnt162b2 (BNT162B2), dose 3 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history  and concomitant medications were not reported.  The patient experienced pain (pain) (medically significant) on an unspecified date with outcome of recovering , held xeljanz in the setting of getting her covid booster and recently resumed (immunisation) (non-serious) on an unspecified date with outcome of unknown.     The lot number for vaccine [BNT162B2] was not provided and will be requested during follow-up.
Patient states that injection site has been hurting since the injection and has now radiated from the arm all the way to the elbow for the past 3 weeks even after applying compressors and taking ibuprofen. No redness or swollen at the site.
This spontaneous report was received from a Licensed Practical Nurse regarding an unspecified number of patient of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date, the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K018183, and expiration date 04-MAY-2015 and lot # K022886, expiration date 09-JUN-2016 and lot number L014458, expiration date 11-FEB-2017 (incorrect product storage). No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Metalic taste feeling of numbness in face with itching started within 25 min. I self medicated with 25mg of Benadryl 15 min before injection because I had the same reaction to the first injection. However it did not prevent the reaction as I hoped it would this time. 30 min post injection I took another 25mg of Benadryl. Once med started working symptoms went away.  At no time did I have difficulty breathing. By midnight I was woken by chills, body aches, and head ache (possibly secondary to the jaw clenching I woke up with too). I took tylenol which did not appear to help which is abnormal for me. Fever, chills, aches continued on throughout the night and through the day into the night. On tylenol fever was noted to be 100.6 Fahrenheit. I was finally able to sleep with tylenol and motrin by 10 pm on 18th for 8 hours. Next day temp was about 97.6 Fahrenheit with mild sweating throughout the day and aches had subsided. Today Jan. 19th all symptoms are gone.
pt recvd vax;devel rhinitis,cough,eyes draining "purulent" material & eyes hurt;sxs worse,very tired,chills,feverish;chest tightened up;difficulty breathing;to hosp via ambulance;pupils became fixed & dilated;bad flu;tx w/ dph IV,dx tests;
March 10 - onset with dizziness March 11 - 12:45 PM while sitting symptoms progressed to vertigo, tingling throughout body, ear pitching sounds, tunneling vision, total blackout and falling from chair.  Upon coming to, symptoms of weakness, in and out of alertness, confusion and diminished responsiveness. Remained on floor for an hour and my symptoms contined for 5 hours until about 6pm.  Had severe hypotension:  no readings upon reaction, but three hours later they were: 4pm - 84/48, 6pm - 94/54, 7pm - 97/58, 9pm - 100/60. Regular readings are 110/90.